Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Unknown 3Completed 2

Sponsor Class

NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Sarcoma 5Wilms Tumor 3Kidney Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 2Gestational Trophoblastic Disease 2Neoplasms 1Malignant mesenchymal tumor 1

Interventions

aldesleukin 9Sunitinib 5Interferon-alpha 4Chemotherapy, Adjuvant 4pembrolizumab 3Vincristine 3Neoadjuvant Therapy 3Dactinomycin 3Cyclophosphamide 3Bevacizumab 3sargramostim 2fludarabine phosphate 2Robotic Surgical Procedures 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Laparoscopy 2Gene Expression Profiling 2Fluorouracil 2Etoposide 2Electroporation 2Doxorubicin 2Carboplatin 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2tremelimumab 1toripalimab 1temsirolimus 1spartalizumab 1pazopanib 1orantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Kidney Neoplasms × Dactinomycin × Clear all
NCT00003804 2014-06-24

Chemotherapy Plus Surgery in Treating Children at Risk of or With Stage I Wilms' Tumor

National Cancer Institute (NCI)

Phase 3 Unknown
350 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

NCT00047138 2014-06-24

Chemotherapy Before and After Surgery in Treating Children With Wilm's Tumor

National Cancer Institute (NCI)

Phase 3 Unknown
350 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

NCT00025103 2013-08-02

Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney

National Cancer Institute (NCI)

Phase 2 Unknown
75 enrolled
Genitourinary

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡